Expertise: Neuroscience 46 results
In CNS trials, inconsistent endpoint assessments can jeopardize outcomes. Premier Research offers customized rater training to reduce variability, minimize placebo response, and improve data quality from the start. Powered by our Remarque™ platform, we deliver real-time monitoring, centralized scoring, and...
The Alzheimer’s research landscape is undergoing a fundamental transformation. With disease-modifying therapies now a reality, sponsors must rethink how they design, recruit for, and execute trials—particularly in early-stage and preclinical populations. This guide explores five strategic imperatives that can help...
For decades, the Alzheimer’s disease (AD) treatment landscape remained largely static, focused on symptom management rather than disease modification. But in recent years, the field has entered a transformational period. With the emergence of new biomarkers, approval of novel anti-amyloid...